Nu-Med Plus (NUMD) Non-Current Assets (2011 - 2022)
Nu-Med Plus (NUMD) reported Non-Current Assets of $2090.0 for Q2 2022, down 78.14% on a YoY basis from $9561.0 in Q2 2021, and up 732.67% sequentially from $251.0 in Q1 2022.
Nu-Med Plus (NUMD) Non-Current Assets (2011 - 2022) Analysis & Trends
Nu-Med Plus (NUMD) has 12 years of Non-Current Assets data on file, last reported at $2090.0 in Q2 2022.
- For the quarter ending Q2 2022, Non-Current Assets fell 78.14% year-over-year to $2090.0; the trailing twelve-month figure through Mar 2023 stood at $2090.0 (changed N/A YoY), and the FY2021 full-year result was $10488.0, down 46.52% from the prior year.
- Non-Current Assets grew to $2090.0 in Q2 2022, from $251.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $44147.0 in Q2 2018 to a low of $251.0 in Q1 2022.
- A 5-year average of $24822.8 and a median of $25502.5 in 2020 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets soared 101.57% in 2018 and slumped 98.2% in 2022, its largest moves.
- Tracing NUMD's Non-Current Assets over 5 years: stood at $36791.0 in 2018, then slipped by 13.51% to $31821.0 in 2019, then slumped by 38.37% to $19612.0 in 2020, then plunged by 46.52% to $10488.0 in 2021, then plunged by 80.07% to $2090.0 in 2022.
- Business Quant data shows NUMD's Non-Current Assets at $2090.0 in Q2 2022, $251.0 in Q1 2022, and $10488.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 2.30 Bn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 26.70 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 20.47 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 2,090.00 |
| Mar 31, 2022 | 251.00 |
| Dec 31, 2021 | 10,488.00 |
| Sep 30, 2021 | 16,563.00 |
| Jun 30, 2021 | 9,561.00 |
| Mar 31, 2021 | 13,970.00 |
| Dec 31, 2020 | 19,612.00 |
| Sep 30, 2020 | 25,256.00 |
| Jun 30, 2020 | 19,477.00 |
| Mar 31, 2020 | 25,749.00 |
| Dec 31, 2019 | 31,821.00 |
| Sep 30, 2019 | 37,879.00 |
| Jun 30, 2019 | 31,611.00 |
| Mar 31, 2019 | 38,055.00 |
| Dec 31, 2018 | 36,791.00 |
| Sep 30, 2018 | 40,565.00 |
| Jun 30, 2018 | 44,147.00 |
| Mar 31, 2018 | 42,924.00 |
| Dec 31, 2017 | 46,509.00 |
| Sep 30, 2017 | 50,095.00 |